spacer
spacer

PDBsum entry 6hgo

Go to PDB code: 
protein ligands Protein-protein interface(s) links
Immune system PDB id
6hgo

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chains
126 a.a.
Ligands
NAG-NAG
NAG ×3
SO4
Waters ×224
PDB id:
6hgo
Name: Immune system
Title: Crystal structure of human il-17f
Structure: Interleukin-17f. Chain: a, b, c, d. Fragment: il-17f. Synonym: il-17f,cytokine ml-1. Engineered: yes
Source: Homo sapiens. Human. Organism_taxid: 9606. Gene: il17f. Expressed in: homo sapiens. Expression_system_taxid: 9606. Expression_system_cell_line: hek293s.
Resolution:
2.10Å     R-factor:   0.200     R-free:   0.220
Authors: J.M.Rondeau,A.Goepfert
Key ref: A.Goepfert et al. (2020). Structural Analysis Reveals that the Cytokine IL-17F Forms a Homodimeric Complex with Receptor IL-17RC to Drive IL-17RA-Independent Signaling. Immunity, 52, 499. PubMed id: 32187518 DOI: 10.1016/j.immuni.2020.02.004
Date:
23-Aug-18     Release date:   20-Nov-19    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chains
Pfam   ArchSchema ?
Q96PD4  (IL17F_HUMAN) -  Interleukin-17F from Homo sapiens
Seq:
Struc:
163 a.a.
126 a.a.
Key:    PfamA domain  Secondary structure

 

 
DOI no: 10.1016/j.immuni.2020.02.004 Immunity 52:499 (2020)
PubMed id: 32187518  
 
 
Structural Analysis Reveals that the Cytokine IL-17F Forms a Homodimeric Complex with Receptor IL-17RC to Drive IL-17RA-Independent Signaling.
A.Goepfert, S.Lehmann, J.Blank, F.Kolbinger, J.M.Rondeau.
 
  ABSTRACT  
 
Interleukin-17A (IL-17A), IL-17F, and IL-17A/F heterodimers are key cytokines of the innate and adaptive immune response. Dysregulation of the IL-17 pathway contributes to immune pathology, and it is therefore important to elucidate the molecular mechanisms that govern IL-17 recognition and signaling. The receptor IL-17RC is thought to act in concert with IL-17RA to transduce IL-17A-, IL-17F-, and IL-17A/F-mediated signals. We report the crystal structure of the extracellular domain of human IL-17RC in complex with IL-17F. In contrast to the expected model, we found that IL-17RC formed a symmetrical 2:1 complex with IL-17F, thus competing with IL-17RA for cytokine binding. Using biophysical techniques, we showed that IL-17A and IL-17A/F also form 2:1 complexes with IL-17RC, suggesting the possibility of IL-17RA-independent IL-17 signaling pathways. The crystal structure of the IL-17RC:IL-17F complex provides a structural basis for IL-17F signaling through IL-17RC, with potential therapeutic applications for respiratory allergy and inflammatory bowel diseases.
 

 

spacer

spacer